AsphyxiaCause of DeathCrowding
Dr. William Lawler, MD
NPI1700886702
- Publications
- 5
- Clinical trials
- 21
- Industry payments
- $13,556
- State licenses
- 2
- Year NPI issued
- 2005
- Practice address
- 2151 N Harbor Blvd, Fullerton, CA 92835-3820
- Practice phone
- Call (714) 446-5900
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Lawler's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. William Lawler is a hematologist and oncologist in Fullerton, California
Dr. Lawler practices in Fullerton, California.
Dr. Lawler's NPI, 1700886702, was assigned on August 1, 2005. Dr. Lawler graduated from Stanford University School Of Medicine in 1967. Dr. Lawler's California license number on file is G16403.
NPI and contact details
- NPI
- 1700886702NPI Registry (opens in a new tab)
- NPI enumeration date
- August 1, 2005
- NPI status
- Active
- Practice phone
- (714) 446-5900
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1967
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. William Lawler's practice address is in Fullerton, California
Dr. Lawler's practice address in the NPI Registry is 2151 N Harbor Blvd, Fullerton, CA 92835-3820. The practice phone is (714) 446-5900.
- NPI Registry address2151 N Harbor Blvd, Fullerton, CA 92835-3820Phone(714) 446-5900
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. William Lawler's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lawler practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Lawler's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Lawler practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. William Lawler is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Lawler's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lawler is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lawler's licenses on file in 2 states: California and Arkansas.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
- Medical oncology, Arkansas
Hematologists and oncologists near Dr. Lawler
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
1,502hematologists and oncologists in California
6hematologists and oncologists in Fullerton
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. William Lawler's patients have a median age of 70
Across all payers, Dmand AI patient panel data puts Dr. Lawler's median patient age at 70, with 78% women.
Dr. Lawler's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women78%
- Men22%
Source: Dmand AI Patient Panel Data
Dr. William Lawler has 5 publications on record
Dmand AI links 5 papers to Dr. Lawler, published from 2015 to 2024. 2024 was the busiest year, with 2. Dr. Lawler's most frequent co-authors are Linda Diana Bosserman, FACP, MD, Fadi S. Braiteh, MD and Thomas M. Cosgriff, MD.
Papers5
Years published2015 to 2024
Dr. Lawler's papers by year, 2015 to 2024
Dr. Lawler's most frequent co-authors
- Linda Diana Bosserman, FACP, MD1 shared paper
- Fadi S. Braiteh, MD1 shared paper
- Thomas M. Cosgriff, MD1 shared paper
Recent publications by Dr. Lawler
Biomarkers, TumorBreast NeoplasmsImmunohistochemistry
See who Dr. Lawler researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lawler works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. William Lawler has worked on 21 clinical trials
Dmand AI links Dr. Lawler to 21 clinical trials, 5 of them phase 3 studies. 12 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Breast Neoplasms. Eli Lilly and Company sponsors the most, 8. Open Payments lists research payments to Dr. Lawler that name 7 trials.
Clinical trials with Dr. Lawler by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 2Phase 2/3: 2 trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Conditions in Dr. Lawler's trials
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
- Breast Neoplasms
- Breast Diseases
- Breast Carcinoma In Situ
Investigators on the most trials with Dr. Lawler
- James Mitchell Granfortuna, MD8 shared trials
- Gregory B. Smith, MD8 shared trials
- Lisa Shing-E Lu Wang, MD8 shared trials
Recent clinical trials with Dr. Lawler
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation (opens in a new tab)
Active, not recruitingPhase 2/3
GliosarcomaGlioblastomaTemozolomideVeliparib
Breast NeoplasmsBreast DiseasesAnastrozoleTrastuzumab Deruxtecan
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer (opens in a new tab)
Active, not recruitingPhase 3
Breast Carcinoma In SituCarcinoma in SituPembrolizumabRadiation Therapy
Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial) (opens in a new tab)
Active, not recruitingPhase 3
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicNivolumab
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers (opens in a new tab)
Active, not recruitingPhase 3
IpilimumabNivolumab
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. William Lawler received $13,556 in industry payments from 2016 to 2025
CMS Open Payments shows 838 general payments to Dr. Lawler from 60 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Genentech, Inc. paid the most, $1,302. It also lists 11 research payments totaling $10,427 from 2016 to 2023, naming 7 clinical trials.
General payments to Dr. Lawler by program year, 2016 to 2025
General payments to Dr. Lawler by kind, 2016 to 2025
$13.6Kin total
- Food and beverage$13,30198%
- Education$2552%
Companies that paid Dr. Lawler the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. William Lawler graduated from Stanford University School Of Medicine
Dr. Lawler graduated from Stanford University School Of Medicine in 1967.
- Medical school
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Sources for Dr. William Lawler's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. William Lawler
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. William Lawler's NPI number?
Dr. William Lawler's NPI number is 1700886702. It was assigned on August 1, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. William Lawler?
Dr. William Lawler is a hematologist and oncologist in Fullerton, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. William Lawler practice?
Dr. Lawler practices at 2151 N Harbor Blvd, Fullerton, CA 92835-3820.
What is Dr. William Lawler's office phone number?
The practice phone on file for Dr. Lawler is (714) 446-5900.
What is Dr. William Lawler's medical license number?
Dr. Lawler's California license number on file is G16403, one of the licenses on file in 2 states.
Which states has Dr. William Lawler been licensed in?
Dmand AI has state licenses on file for Dr. Lawler in California (1969 to 2024) and Arkansas.
Is Dr. William Lawler board certified?
Yes. Dr. Lawler is board certified in hematology by the American Board of Internal Medicine.
Where did Dr. William Lawler go to medical school?
Dr. Lawler graduated from Stanford University School Of Medicine in 1967.
Has Dr. William Lawler received payments from drug or device companies?
CMS Open Payments shows $13,556 in general payments to Dr. Lawler from 60 companies from 2016 to 2025. The largest total came from Genentech, Inc.
How long has Dr. William Lawler been practicing?
Dr. Lawler graduated from medical school in 1967, 59 years ago.
Does Dr. William Lawler do research?
Dmand AI links 5 publications to Dr. Lawler, published from 2015 to 2024. Dr. Lawler has worked on 21 clinical trials.
Who does Dr. William Lawler publish with?
Dr. Lawler's most frequent co-authors are Linda Diana Bosserman, FACP, MD (1 shared paper), Fadi S. Braiteh, MD (1 shared paper) and Thomas M. Cosgriff, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card